Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 16, 2015 07:55 ET | Source: Emisphere Technologies, Inc.

Emisphere Reports Third Quarter 2015 Financial Results

ROSELAND, N.J., Nov. 16, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the third quarter ended September 30, 2015, and provided a corporate...
November 10, 2015 16:35 ET | Source: Emisphere Technologies, Inc.

Emisphere Announces Third Quarter 2015 Financial Results Conference Call

ROSELAND, N.J., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that Management will host a conference call on Monday, November 16, 2015, at 8:30 AM ET to...
November 05, 2015 16:15 ET | Source: Emisphere Technologies, Inc.

Emisphere to Present at SeeThruEquity MicroCap Investor Forum

ROSELAND, N.J., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that President and Chief Executive Officer, Alan L. Rubino, will present at the...
October 15, 2015 08:20 ET | Source: Emisphere Technologies, Inc.

Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement

ROSELAND, N.J., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. today announced that it has entered into a Development and License Agreement with Novo Nordisk A/S (NYSE:NVO) to...
September 02, 2015 16:15 ET | Source: Emisphere Technologies, Inc.

Emisphere to Present at Rodman and Renshaw 17th Annual Global Investment Conference

ROSELAND, N.J., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that President and Chief Executive Officer, Alan L. Rubino, will present at the Rodman and...
August 26, 2015 09:38 ET | Source: Emisphere Technologies, Inc.

Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral Semaglutide, a Once Daily Oral GLP-1

ROSELAND, N.J., Aug. 26, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today highlighted that Eligen® licensee Novo Nordisk A/S (NYSE:NVO) will initiate a global phase 3a...
August 12, 2015 08:00 ET | Source: Emisphere Technologies, Inc.

Emisphere Reports Second Quarter 2015 Financial Results

ROSELAND, N.J., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the quarter ended June 30, 2015, and provided a corporate...
August 06, 2015 16:30 ET | Source: Emisphere Technologies, Inc.

Emisphere Announces Second Quarter 2015 Financial Results Conference Call

ROSELAND, N.J., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCQB:EMIS) announced today that Management will host a conference call on Wednesday, August 12, 2015, at 8:30 AM ET to...
May 15, 2015 08:00 ET | Source: Emisphere Technologies, Inc.

Emisphere Reports First Quarter 2015 Financial Results

ROSELAND, N.J., May 15, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the first quarter ended March 31, 2015, and provided an overview of...
May 11, 2015 16:15 ET | Source: Emisphere Technologies, Inc.

Emisphere Announces First Quarter 2015 Financial Results Conference Call

ROSELAND, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCQB:EMIS) announced today that management will host a conference call on Friday, May 15, 2015, at 8:30 AM EDT to...